NOVADISCOVERY

novadiscovery-logo

novadiscovery is a developer of a drug discovery platform in silico clinical trials designed to de-risk, optimize research and development along with curbing the cost of discovering new drugs. The company's platform uses mathematics and intelligent algorithms to build a community of virtual patients as on-demand digital lab rats, enabling scientists and biotech, pharma companies to predict drug efficacy and create the target combination.

#People #Financial #Website #More

NOVADISCOVERY

Industry:
Artificial Intelligence Biotechnology CRM Health Care Information Technology Medical

Founded:
2010-01-01

Address:
Lyon, Rhone-Alpes, France

Country:
France

Website Url:
http://www.novadiscovery.com

Total Employee:
11+

Status:
Active

Contact:
33463600506

Total Funding:
8.58 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager WordPress Sitelinks Search Box Euro IPv6 Yoast WordPress SEO Plugin ReCAPTCHA



Current Advisors List

alex-gouaillard_image

Alex Gouaillard Member of the Strategic Advisory Board @ Novadiscovery
Advisor
2015-02-01

isabelle-vitali_image

Isabelle Vitali Board Member @ Novadiscovery
Board_member
2021-02-01

tero-silvola_image

Tero Silvola Board Member @ Novadiscovery
Board_member
2020-02-01

Current Employees Featured

françois-henri-boissel_image

François-Henri Boissel
François-Henri Boissel CO-FOUNDER & CHIEF EXECUTIVE OFFICER @ Novadiscovery
CO-FOUNDER & CHIEF EXECUTIVE OFFICER
2010-04-01

Founder


françois-henri-boissel_image

François-Henri Boissel

Investors List

sanofi_image

Sanofi

Sanofi investment in Series A - Novadiscovery

debiopharm_image

Debiopharm Group

Debiopharm Group investment in Series A - Novadiscovery

big-booster_image

BIG BOOSTER

BIG BOOSTER investment in Seed Round - Novadiscovery

h2020_image

H2020

H2020 investment in Grant - Novadiscovery

Official Site Inspections

http://www.novadiscovery.com

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Novadiscovery"

Novadiscovery - Crunchbase Company Profile & Funding

Novadiscovery is a developer of a drug discovery platform in silico clinical trials designed to de-risk, optimize research and development along with curbing the cost of discovering new drugs. The company's platform uses mathematics and …See details»

Nova Discovery's Story - Nova In Silico

May 12, 2022 · From its early days to the latest developments of NOVA’s innovative approach, discover the history behind Nova Discovery.See details»

Leadership - Nova In Silico

As Novadiscovery’s co-founder and CEO from 2010 to 2024, François-Henri honed a variety of skills ranging from corporate strategy to business development, corporate governance, and people management.See details»

Nova In Silico - Better trials. Faster insights.

Our interdisciplinary team combines expertise in biology, medicine, clinical pharmacology, applied mathematics, data science, artificial intelligence and software development. Want to try the …See details»

Novadiscovery Company Profile - Office Locations, Competitors

Apr 13, 2022 · See insights on Novadiscovery including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Debiopharm's portfolio company Novadiscovery - Debiopharm

With AI and virtual populations at the heart Nova’s in silico clinical trials platform Jinkō, Nova builds mathematical models of disease and treatment to optimise trial design, to capture best …See details»

Novadiscovery - Overview, News & Similar companies - ZoomInfo

Apr 13, 2022 · Novadiscovery contact info: Phone number: +33 972531300 Website: www.novadiscovery.com What does Novadiscovery do? Founded in 2010, Novadiscovery is a …See details»

Novadiscovery raises series A financing to scale its in silico clinical ...

Jan 9, 2020 · Novadiscovery has developed a hybrid platform blending mechanistic models with artificial intelligence (AI), which goal is to de-risk R&D decisions by predicting the clinical …See details»

Sanofi invests in health tech firm Novadiscovery, …

Feb 17, 2021 · Sanofi is funneling €2.5 million into French clinical trial simulation specialist Novadiscovery as it looks to beef up its COVID-19 trial response. Novadiscovery uses its so-called JINKO...See details»

Novadiscovery Raises Series A Financing to Scale its in silico …

Jan 9, 2020 · Novadiscovery has developed a hybrid platform blending mechanistic models with artificial intelligence (AI), which goal is to de-risk R&D decisions by predicting the clinical …See details»

Novadiscovery Carries out Clinical Trials using AI and …

Feb 14, 2020 · Novadiscovery, based in Lyon, France, is developing AI-based simulation technology to predict clinical trial outcomes and cut their running costs. Mission: To predict the outcomes of clinical trials in silico using a combination …See details»

NOVA management team highlights - LinkedIn

May 3, 2022 · At NOVA, I have the opportunity to work with a wonderful team of more than 45 talented biomodelers, supported by a great team of software engineers. So it is a dream for …See details»

Novadiscovery Continues Global Expansion with the Launch of

Lyon, France – 2 November 2021: Novadiscovery (NOVA), a leading health tech company using in silico clinical trials to predict drug efficacy and accelerate clinical development, today …See details»

Novadiscovery raises series A financing to scale its in

Jan 9, 2020 · Novadiscovery has developed a hybrid platform blending mechanistic models with artificial intelligence (AI), which goal is to de-risk R&D decisions by predicting the clinical …See details»

Novadiscovery raises Series A2 financing from Sanofi to

Feb 16, 2021 · Novadiscovery raises Series A2 financing from Sanofi to advance JINKO, its best-in-class clinical trial simulation platform. NOVA to develop COVID-19 disease model to …See details»

Novadiscovery - YouTube

Learn more about NOVA and in silico clinical trials through this interview of François-Henri Boissel our CEO. This interview emphasizes the following topics: - What is NOVA? - The impact...See details»

Novadiscovery announces new clinical simulation - GlobeNewswire

Lyon, France – 26 March, 2021 Novadiscovery (“NOVA”), a leading health tech company offering JINKO, a best-in-class clinical trial simulation platform to predict drug efficacy and optimize...See details»

A standout 2021 supports in silico trials - Novadiscovery

Feb 14, 2022 · 2021 was a standout year for drug development. The US FDA approved a record number of new drugs, on top of passing Emergency Use Authorisations for Covid-19 vaccines …See details»

Novadiscovery Reviews: What Is It Like to Work At ... - Glassdoor

Jul 5, 2023 · Novadiscovery has an overall rating of 4.7 out of 5, based on over 26 reviews left anonymously by employees. 93% of employees would recommend working at Novadiscovery …See details»

Novadiscovery announces Nature Communications paper on

Apr 13, 2022 · Novadiscovery announces Nature Communications paper on modeling the disruption to respiratory clinical trials due to mitigation measures against COVID-19. Model …See details»

linkstock.net © 2022. All rights reserved